Biocryst Pharmaceuticals Inc stock is traded at $7.63, with a volume of 14,780,932. It is down -7.40% in the last 24 hours and down -5.80% over the past month. BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Previous Close:
$8.24
Open:
$8.28
24h Volume:
14,780,932
Relative Volume:
2.33
Market Cap:
$1.95B
Revenue:
$885.72M
Net Income/Loss:
-$457.98M
P/E Ratio:
-
EPS:
-$1.78
Net Cash Flow:
$293.05M
1W Performance:
-10.45%
1M Performance:
-5.80%
6M Performance:
-15.50%
1Y Performance:
+6.42%
1-Day Range:
$7.42$8.28
1-Week Range:
$7.42$8.86
52-Week Range:
$6.23$11.22
Biocryst Pharmaceuticals Inc Stock (BCRX) Company Profile
Name
Biocryst Pharmaceuticals IncSector
HealthcarePhone
919-859-1302Address
4505 EMPEROR BOULEVARD, DURHAM, NC, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS